[Corrigendum] Methylation‑regulated ZNF545 inhibits growth of the p53‑mutant KYSE150 cell line by inducing p21 and Bax

Fan,Yu; Wang,Yu; Fu,Shaozhi; Liu,Duan; Lin,Sheng

doi:10.3892/etm.2021.9948

May-2021 Volume 21 Issue 5

Full Size Image

Journals

International Journal of Molecular Medicine

International Journal of Molecular Medicine is an international journal devoted to molecular mechanisms of human disease.

International Journal of Oncology

International Journal of Oncology is an international journal devoted to oncology research and cancer treatment.

Molecular Medicine Reports

Covers molecular medicine topics such as pharmacology, pathology, genetics, neuroscience, infectious diseases, molecular cardiology, and molecular surgery.

Oncology Reports

Oncology Reports is an international journal devoted to fundamental and applied research in Oncology.

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine is an international journal devoted to laboratory and clinical medicine.

Oncology Letters

Oncology Letters is an international journal devoted to Experimental and Clinical Oncology.

Biomedical Reports

Explores a wide range of biological and medical fields, including pharmacology, genetics, microbiology, neuroscience, and molecular cardiology.

Molecular and Clinical Oncology

International journal addressing all aspects of oncology research, from tumorigenesis and oncogenes to chemotherapy and metastasis.

World Academy of Sciences Journal

Multidisciplinary open-access journal spanning biochemistry, genetics, neuroscience, environmental health, and synthetic biology.

International Journal of Functional Nutrition

Open-access journal combining biochemistry, pharmacology, immunology, and genetics to advance health through functional nutrition.

International Journal of Epigenetics

Publishes open-access research on using epigenetics to advance understanding and treatment of human disease.

Medicine International

An International Open Access Journal Devoted to General Medicine.

May-2021 Volume 21 Issue 5

Full Size Image

Correction Open Access

[Corrigendum] Methylation‑regulated ZNF545 inhibits growth of the p53‑mutant KYSE150 cell line by inducing p21 and Bax

Authors:
- Yu Fan
- Yu Wang
- Shaozhi Fu
- Duan Liu
- Sheng Lin
View Affiliations / Copyright

Affiliations: Department of Oncology, The Affiliated Hospital of Southwest Medical University, Luzhou, Sichuan 646000, P.R. China, Department of Health Examination, The Affiliated Hospital of Southwest Medical University, Luzhou, Sichuan 646000, P.R. China

Copyright: © Fan et al. This is an open access article distributed under the terms of Creative Commons Attribution License [CC BY 4.0].
Article Number: 517
|
Published online on: March 22, 2021

https://doi.org/10.3892/etm.2021.9948
Expand metrics +

Article

Exp Ther Med 18:[Related article:] 1563-1570, 2019; DOI: 10.3892/etm.2019.7737

Subsequently to the publication of this article, the authors have realized that they were unable to replicate the data shown in Fig. 1C in repeated experiments; moreover, the wrong MSP images had been incorporated into Fig. 1C, and the correct data were lost.

Figure 1

ZNF545 expression is downregulated by methylation in ESCC tissues. (A) ZNF545 mRNA expression was significantly reduced in primary ESCC tissues when compared with adjacent noncancer samples (n=15), according to reverse transcription-quantitative PCR analysis. (B) ZNF545 mRNA expression was restored in KYSE150 cells following treatment with the demethylating reagent, 5-Aza-2’-deoxycytidine, and the histone deacetylase inhibitor, trichostatin A. ZNF545, zinc finger protein 545; ESCC, esophageal squamous cell carcinoma; A + T, 5-Aza-2’-deoxycytidine and trichostatin A.

All authors agreed that the problem with these data could be rectified by simply omitting the affected Figure part, and that this would not have a major impact on the conclusions reported in the paper. The corrected version of Fig. 1, with the omission of Fig. 1C and its revised legend, are shown opposite. As a consequence of the correction to the figure, note that the pair of sentences in the Results section on p. 1565, right-hand column, starting from line 9 should now read as follows: “The promoter methylation status of ZNF545 in tumor tissues (n=64) and adjacent normal tissues (n=64) was also evaluated using an MSP assay. ZNF545 promoter methylation was observed in 76.6% (49/64) of primary tumors, compared with only 28.1% (28/64) of adjacent normal tissues (P<0.001; Table II).” All the authors agree with the publication of this Corrigendum, regret this error that was only noticed subsequently to the publication of the article, and apologize to the readership for any inconvenience caused.

Journals

International Journal of Molecular Medicine

International Journal of Oncology

Molecular Medicine Reports

Oncology Reports

Experimental and Therapeutic Medicine

Oncology Letters

Biomedical Reports

Molecular and Clinical Oncology

World Academy of Sciences Journal

International Journal of Functional Nutrition

International Journal of Epigenetics

Medicine International

[Corrigendum] Methylation‑regulated ZNF545 inhibits growth of the p53‑mutant KYSE150 cell line by inducing p21 and Bax

This article is mentioned in:

Article

Figure 1

Related Articles